[ET Net News Agency, 10 January 2022] INNOVENT BIO (01801) rose 5.22% to HK$42.3.
It hits an intra-day high of HK$42.4, and an intra-day low of HK$39.8. The total shares
traded was 1.08 million, with a value of HK$44.14m. The active buy/sell ratio is 59:41,
with net buying turnover of HK$7.42m. MORGAN STANLEY HK SEC accounts for greatest net
responsive buying turnover of HK$2.96m, with volume weighted average price of HK$40.936.
CLSA LTD accounts for greatest net responsive selling turnover of HK$4.11m, with volume
weighted average price of HK$40.858. The stock has risen a combined 6.82% over the past 2
consecutive trading days.
The Hang Seng Index now rose 177 points, or 0.76% to 23,671; the Hang Seng China
Enterprises Index now rose 79 points, or 0.96% to 8,310; the Hang Seng TECH Index now rose
66 points, or 1.21% to 5,570; with an overall turnover of HK$29.77b.
The SSE Composite Index now fell 15 points, or 0.43% to 3,564, with an overall turnover
of RMB143.8b.
The SZSE Component Index now fell 57 points, or 0.4% to 14,285, with an overall turnover
of RMB94.89b.
Basic Information
=================
---------------------------------
Nominal 42.300 % Chg +5.22%
High 42.400 Low 39.800
Shares Tr 1.08m Turnover 44.14m
10-D SMA 43.520 %H.V 70.037
20-D SMA 49.222 VWAP 40.946
50-D SMA 62.719 RSI14 30.242
---------------------------------
Status: Active buy/sell ratio is 59:41, with net buying turnover of HK$7.42m, rising a
combined 6.82% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
INNOVENT BIO (01801) 42.30 +5.22
GENSCRIPT BIO (01548) 31.55 +1.28
JUNSHI BIO (01877) 44.55 +6.96
JXR (01951) 8.29 +2.60
WUXI BIO (02269) 82.35 +1.98
TIGERMED (03347) 85.40 +1.67
CANSINOBIO-B (06185) 175.50 +8.47
IMMUNOTECH-B (06978) 16.36 -2.62
AKESO-B (09926) 28.80 +2.31
KINTOR PHARMA-B (09939) 11.10 -3.31
-----------------------------------------------
(ed)